Month: March 2021

Stephen Manderson, aka Professor Green, is on a mission to help people improve their gut health, and being honest about what’s happening inside is a good place to start Stephen Manderson is a man on a mission. He wants more people to talk. Specifically, he wants them to talk about gut health, bowel movements and
0 Comments
Two drugs, a dietary supplement, and some devices have been recalled for mislabeled dosages, hidden ingredients, possible injuries and more. The recalled items span uses for high blood pressure, herpes infections, sexual enhancement, pre-surgical swabs and children’s cardiac surgery The first recall is for telmisartan, brand name Micardis, which is used to control high blood
0 Comments
Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS, principal investigator of the DRCR Retina Network Coordinating Center, Tampa, Florida. “Some clinicians may decide
0 Comments
VANCOUVER, Washington, March 30, 2021 (GLOBE NEWSWIRE) – CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, is pleased to announce further results from its CD12 trial of severe-to-critically ill patients with COVID-19. Upon further statistical analysis of the critically
0 Comments
vadadustat Treatment for Anemia Associated with Chronic Renal Failure Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis CAMBRIDGE, Mass., March 30, 2021 /PRNewswire/ – Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of
0 Comments
DUBLIN, March 30, 2021 /PRNewswire/ – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include a new indication to treat newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in pediatric patients aged one year and older. The approval of Vyxeos for this indication
0 Comments
News FDA Alerts Namoo Enterprise LLC Issues Voluntary Nationwide Recall of PremierZen Black 5000 Due to the Presence of Undeclared Sildenafil and Tadalafil March 26, 2021 Audience: Consumer March 26, 2021 — Little Ferry, NJ, Namoo Enterprise LLC is voluntarily recalling all lots within expiry of PremierZen Black 5000 capsules to the consumer level. FDA
0 Comments
In this article AZN-GB Medical syringes and small figurines of people are seen in front of the AstraZeneca logo displayed on a screen. On Saturday, March 26, 2021, in Dublin, Ireland. NurPhoto | NurPhoto | Getty Images Germany has suspended use of the coronavirus vaccine created by AstraZeneca and the University of Oxford in the
0 Comments
Too often, contends UMass Lowell faculty researcher Brenna Morse, children with complex chronic medical conditions spend days in the hospital undergoing tests for what could be a simple diagnosis. The challenges include, she says, some children with medical complexities, such as severe neurological conditions and functional impairments, cannot easily signal that they are in pain
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two-thirds of epidemiologists from leading academic institutions say the world will need new or modified vaccines for COVID-19 within a year, new research show.. In a survey of 77 epidemiologists from 28 countries by the People’s Vaccine Alliance, 66.2% predicted the
0 Comments
Jon Holley is a trauma and orthopaedic surgeon and co-founder of TEDxNHS – a place for empowering talks for the NHS, by the NHS *Trigger warning: Themes around a baby’s death. My beautiful son Theo died seven years ago. Five weeks into his short life, the magical delight and abundant possibility of the night he
0 Comments
Since the early days of Donald Trump’s campaign, mental health professionals have come forth in unprecedented ways to warn against entrusting the U.S. presidency to someone whose mental fitness for the Oval Office was more than suspect.  In early 2017, I organized an ethics conference at Yale School of Medicine to clarify our public health duty,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Obesity rates among children jumped substantially in the first months of the COVID-19 pandemic, according to a study published online in Pediatrics. Experts worry the excess weight will be a continuing problem for these children. “Across the board in the span
0 Comments
insights from industryDavid MaceChief Executive OfficerSwiftScale Biologics In this interview, News-Medical talks to David Mace, Chief Executive Officer at SwiftScale Biologics, about the work they do and how their partnership with Sartorius benefits both parties Please could you give an overview of SwiftScale, the work you do and your partnership with Sartorius? We are a
0 Comments
maralixibat Treatment for Cholestatic Pruritus in Patients with Alagille Syndrome Mirum Pharmaceuticals Announces FDA Acceptance of New Drug Application and Priority Review for Maralixibat in Alagille Syndrome FOSTER CITY, Calif.–(BUSINESS WIRE)–Mar. 29, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced today that its New Drug Application (NDA) for maralixibat, an oral apical sodium dependent bile acid transporter (ASBT)
0 Comments
TOKYO, March 26, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) approved Myrbetriq (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq Granules
0 Comments
March 25, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy March 25, 2021 — Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. is voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after receiving several complaints of crystallization in vials. Administration of crystalized Acyclovir Sodium Injection, 50
0 Comments
The discovery of multiple effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offers a path out of the global pandemic that has already claimed over 2.79 million lives from over 127 million infections worldwide. The success of global vaccination will depend on achieving herd immunity, either by individuals acquiring immunity through vaccination or
0 Comments
Cognitive impairment occurred more than twice as often in patients with normotensive glaucoma (NTG) as compared with high-tension glaucoma (HTG) and exhibited a trend toward greater impairment, a matched case-control study showed. A telephone-based cognitive assessment questionnaire showed that 14.8% of patients with NTG met criteria for cognitive impairment versus 5.4% of patients with HTG.
0 Comments
By Barbara Falkowitz my husband, Phil, was diagnosed with multiple myeloma (MM) 25 years ago, I was 43 and we had a 14 yr old and 9 yr old twins. I was juggling working in an accounting office, homework, after-school activities of three kids, along with household chores. Suddenly, I had to add researching treatment
0 Comments
Channel 4 Dispatches investigates latest figures which show that black women are just over four times more likely to die during pregnancy and childbirth and up to six weeks postpartum On Channel 4 Dispatches: The Black Maternity Scandal, presenter and mum of two Rochelle Humes investigates the shocking increase in the likelihood of death during
0 Comments